Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2003
05/15/2003US20030092190 Method and device for testing aldehyde in polyester polymer
05/15/2003US20030092188 Placental protein 13
05/15/2003US20030092187 Method of detecting the release of substances from cell organelles by means of flow cytometry
05/15/2003US20030092186 Automated system and method for processing multiple liquid-based specimens
05/15/2003US20030092184 Utilization of blood product as control; insert control product in measurement apparatus, analyze position of control products, record results, diagnose apparatus defects
05/15/2003US20030092174 Tissues or organs for use in xenotransplantation
05/15/2003US20030092170 Apparatus for use in the collecting and processing specimens of particulate matter
05/15/2003US20030092159 Efficient purification of proteasomes from cells; immobilizing ubiquitin amino acid sequence to solid support, incubate with cell lysate, elute proteasome from solid support
05/15/2003US20030092147 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092133 Interleukins-21 and 22
05/15/2003US20030092129 Nervous system polypeptide for use in the treatment of nervous system disorders
05/15/2003US20030092122 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092120 Novel human K+ ion channel and therapeutic applications thereof
05/15/2003US20030092115 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092113 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092111 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092110 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092108 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092107 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092106 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092105 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092104 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092103 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092102 Nucleic acids, proteins, and antibodies
05/15/2003US20030092095 Screening, diagnostic and therapeutic methods relating to RIZ
05/15/2003US20030092094 Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies
05/15/2003US20030092093 Extrasomatic diagnostics
05/15/2003US20030092092 Immunoassay for detecting human tryptase autoantibody immune complex; coat a solid support with confining antibodies, block solid support, incubate with binding buffers, mix with detection antibodies, detect presence of tryptase complex
05/15/2003US20030092090 Rapid prion-detection device, system, and test kit
05/15/2003US20030092089 Method for diagnosing multiple sclerosis and an assay therefore
05/15/2003US20030092088 Kit for use in the classification of mammalian blood
05/15/2003US20030092086 Method for detecting streptococcus sobrinus and antibody therefor
05/15/2003US20030092084 EBV-infected stomach cancer cell line
05/15/2003US20030092082 Anti-human luteinizing hormone-related antibodies and uses thereof
05/15/2003US20030092081 Quantitative optical analysis of cells labeled with a fluorescent dye; provide layer of labeled cells, expose to light, mix with masking dye, detect and analyze fluorescence from cells
05/15/2003US20030092080 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
05/15/2003US20030092079 Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions
05/15/2003US20030092078 Propagating and recovering preferential cells from culture; obtain cell sample, expose to antibody, separate cells bound to antibody, recover and propagate bound cells
05/15/2003US20030092076 Determination of concentration of several proteins in sample; obtain protein samples, label each with probe, mix protein sample, determine the ratio of isotope signals, differences in ratio indicate different concentration of proteins
05/15/2003US20030092075 Aldehyde chemical surface activation processes and test methods for colorimetric resonant sensors
05/15/2003US20030092074 Detection of preferential antigen in fluid sample; obtain test sample, deposit on preferential positions on solid support; detect antigen bound antibody
05/15/2003US20030092072 Rapid methods for identifying modifiers of cellular apoptosis activity
05/15/2003US20030092071 Detection of modulator of receptor bind; obtain receptor sample, incubate with test compound, mix with substrate, monitor phosphorylation of receptor; for use as treatment for nervous system disorders
05/15/2003US20030092070 Genetic construct intracellular monitoring system
05/15/2003US20030092067 Libraary of enzyme inhibitor or use in the treatment of cancer and parasitic disease
05/15/2003US20030092066 Purified Stat proteins and methods of purifying thereof
05/15/2003US20030092062 Immobilizing biological molecules
05/15/2003US20030092061 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferation and tumor disorders
05/15/2003US20030092060 Chemiluminescent compounds and use thereof
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030092057 Detection of ligands for preferential polypeptides; obtain sample, incubate with ligand sample, detect bound ligand
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030092051 Pyrophosphorolysis activated polymerization (PAP): application to allele-specific amplification and nucleic acid sequence determination
05/15/2003US20030092047 Diagnosing cancer in humans; obtain nucleotide sequences, incubate with probe, monitor expression and compare pattern to, evaluate for cell proliferative disorders
05/15/2003US20030092042 Diagnosing cancer in mammals; obtain tissue sample, extract nucleotide sequences, detect galinin gene, determine copy number for gene, compare to control, amplified copy number indicates cancer
05/15/2003US20030092041 Novel use for muscarinic receptor M5 in the diagnosis and treatment of metabolic disorders
05/15/2003US20030092040 Apparatus for use in the diagnosis and detection of genetic disorders
05/15/2003US20030092036 Nucleotide sequences coding polypeptide for use in the treatment and prevention of brain and pancreatic disorders
05/15/2003US20030092031 Methods for the detection, analysis and isolation of nascent proteins
05/15/2003US20030092029 Magneitc-nanoparticle conjugates and methods of use
05/15/2003US20030092027 Nuclear magnetic resonance method for identifying ligands to target compounds
05/15/2003US20030092025 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment, prevention of tumor disorders
05/15/2003US20030092024 Essential bacterial genes and their use
05/15/2003US20030092022 Detection of preferential nucleotide sequences in libray; encapsulate library clones, incubate with oligonucleotides, detect clones which hybridized probe, separate and recover clones demonstrating signal
05/15/2003US20030092020 Optimizing waste treatment system; obtain wastewater sample, recover solids, isolate nucleotide sequences from solids, amplify sequences, evaluate waste treatment process for removal of impurities
05/15/2003US20030092016 Microfluidics apparatus and methods for use thereof
05/15/2003US20030092011 Human cDNAs and proteins and uses thereof
05/15/2003US20030092009 Diagnosis of tumors in humans; obtain sample tissue, extract nucleotide sequences, expose to tumor preferential marker, detect signal, signal form sample indicates tumors
05/15/2003US20030092008 Method and apparatus for multiplex flow cytometry analysis of diverse mixed analytes from bodily fluid samples
05/15/2003US20030092006 Classification of preferential nucleotide sequences; obtain nucleotide sequences, insert into vector, transform cells, generate clones, generate ribonucleic acid from clones, divide sequences, amplify and measure sequence concentration
05/15/2003US20030092005 Sequences determination of preferential nucleotide sequences; obtain nucleotide sequences, denatrue, incubate with primers and polymerases, amplify, recover products, determine nucleotide sequence of sample
05/15/2003US20030092002 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030091994 Diagnosis via detection hybridization pattern of chromosomal probes; biopsies
05/15/2003US20030091993 Use and screening method for an aberrant gene product-operating substance
05/15/2003US20030091992 Nutrients broth for use in the cytological and molecular analysis
05/15/2003US20030091991 Gene detecting method and test kit
05/15/2003US20030091990 Methods and compositions involving thymidine phosphorylase as a marker for HIV infection, aids progression, and drug resistance
05/15/2003US20030091987 Materials and methods for detecting, preventing, and treating retroviral infection
05/15/2003US20030091986 Identification of expressed genes using phage display
05/15/2003US20030091985 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
05/15/2003US20030091983 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/15/2003US20030091982 Cell culture for use as model in the treatment of nervous sytem disorders
05/15/2003US20030091981 Kit for use in the deetction of genes associated with xylogenesis
05/15/2003US20030091980 Detection of psychoactive drugs in in vitro neuronal tissue sample; obtain neuronal tissue sample, monitor oscillation of electrical impulses, compare impulses, detect presence of psychoactive drugs
05/15/2003US20030091977 Assessment method
05/15/2003US20030091976 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
05/15/2003US20030091975 Multiple determinants for metabolic phenotypes
05/15/2003US20030091974 Detecting compounds capable of exhausting mast cells; culture mast cells, incubate with modulator, measure mast cell death, classify compound
05/15/2003US20030091973 Method of identifying osteoregenerative agents using differential gene expression
05/15/2003US20030091676 Sample mounting press
05/15/2003US20030091594 CD4-independent HIV envelope proteins as vaccines and therapeutics
05/15/2003US20030091582 Autoimmune diseases; antitumor agents; antiallergens
05/15/2003US20030091581 Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes
05/15/2003US20030091573 Methods and compositions for the diagnosis and treatment of hematological disorders using 16319
05/15/2003US20030091572 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/15/2003US20030091571 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/15/2003US20030091570 Analgesics; antiinflammatory agents; analyzing drug as to ability to modulation gene expression
05/15/2003US20030091569 Methods for the treatment of carcinoma
05/15/2003US20030091566 Antitumor agents
05/15/2003US20030091551 Tyrosone kinase as insulin receptor; antidiabetic agents
1 ... 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 2607 2608 2609 2610 ... 3937